Submission Details
| 510(k) Number | K093678 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | November 27, 2009 |
| Decision Date | January 13, 2011 |
| Days to Decision | 412 days |
| Submission Type | Traditional |
| Review Panel | Microbiology (MI) |
| Summary | Summary PDF |
K093678 is an FDA 510(k) clearance for the PLATELIA ASPERGILLUS EIA MODEL 62793, a Antigen, Galactomannan, Aspergillus Spp. (Class I — General Controls, product code NOM), submitted by Bio-Rad (Redmond, US). The FDA issued a Cleared decision on January 13, 2011, 412 days after receiving the submission on November 27, 2009. This device falls under the Microbiology review panel. Regulated under 21 CFR 866.3040.
| 510(k) Number | K093678 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | November 27, 2009 |
| Decision Date | January 13, 2011 |
| Days to Decision | 412 days |
| Submission Type | Traditional |
| Review Panel | Microbiology (MI) |
| Summary | Summary PDF |
| Product Code | NOM — Antigen, Galactomannan, Aspergillus Spp. |
| Device Class | Class I — General Controls |
| CFR Regulation | 21 CFR 866.3040 |
| Definition | The Platelia Aspergillus Eia Is An Immunoenzymatic Sandwich Microplate Assay For The Detection Of Aspergillus Galactomannan Antigen In Human Serum. It Is A Test Which, When Used In Conjunction With Other Diagnostic Procedures Such As Microbiological Culture, Histological Examination Of Biopsy Samples And Radiographic Evidence, Can Be Used As An Aid In The Diagnosis Of Invasive Aspergillosis. |